Freshfields Bruckhaus Deringer and Baker & McKenzie have taken lead roles on Abbott Laboratories' $7.1bn (£4.5bn) acquisition of pharma company Solvay's drug unit, reports The Am Law Daily. Solvay turned to a team from Freshfields led by corporate partners Geert Verhoeven in Brussels and Timothy Wilkins in New York.
September 29, 2009 at 04:22 AM
1 minute read
The original version of this story was published on Legalweek
Freshfields Bruckhaus Deringer and Baker & McKenzie have taken lead roles on Abbott Laboratories’ $7.1bn (£4.5bn) acquisition of pharma company Solvay’s drug unit, reports The Am Law Daily.
Solvay turned to a team from Freshfields led by corporate partners Geert Verhoeven in Brussels and Timothy Wilkins in New York.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
The premier educational and networking event for employee benefits brokers and agents.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
